Pharmaceutical Investing Turing Pharmaceuticals Backtracks After 5,000-percent Price Increase for Daraprim
Cartier Resources Announces Subscription Agreement for Flow-Through Units Under Its Previously Announced Brokered Offering and Adjustments Further to Tax Measures Unveiled by the Quebec Minister of Finance
